🔴 Pyxis Oncology is trading 5.6% down today following a $50 million private placement and analyst updates

Pyxis Oncology is trading at $2.87 (5.6% down) in pre-market on August 4, 2026, easing after a sharp rebound in the prior session.

• The company recently announced a private placement to raise approximately $50 million, with potential for additional warrant financing.
• The move follows fresh analyst coverage and updated price targets, contributing to recent price volatility.
• Pre-market weakness appears to be normal consolidation following a period of high volatility within a broadly risk-on market environment.